Introduction Progress toward hepatitis C virus (HCV) elimination is impeded by low testing
and treatment due to the current diagnostic pathway requiring multiple visits leading to loss …

Amplification of drug resistance in Mycobacterium tuberculosis (M. tb) and its transmission
are significant barriers in controlling tuberculosis (TB) globally. Diagnostic inaccuracies and …

The transition to a value-based payment system offers pathologists the opportunity to play
an increased role in population health by improving outcomes and safety as well as …

Background The dual challenge of low diagnostic sensitivity of microscopy test and technical
challenge of performing a TB culture test poses a problem for case detection and initiation of …

Background Despite progress in TB control in low-burden countries like England and Wales,
there are still diagnostic delays. Molecular testing and/or whole-genome sequencing (WGS) …

Resistance to the first-line antituberculosis (TB) drug isoniazid (INH) is widespread, and the
mechanism of resistance is unknown in approximately 15% of INH-resistant (INH-R) strains …

Background Tuberculosis (TB) control is hindered by absence of rapid tests to identify
Mycobacterium tuberculosis (MTB) and detect isoniazid (INH) and rifampin (RIF) resistance …

Drug-resistant tuberculosis (DR-TB) is challenging to diagnose, treat, and prevent, but this
situation is slowly changing. If the world is to drastically reduce the incidence of DR-TB, we …

Background Point-of-care tests for chlamydia (CT) and gonorrhoea (NG) could increase the
uptake and timeliness of testing and treatment, contribute to improved disease control and …

Abstract Drug Resistant Tuberculosis (DRTB) is an emerging problem world-wide. In order
to control the disease and decrease the number of cases overtime a prompt diagnosis …